A Promising Breakthrough: Bravo's Anti-Inflammatory Power
Dear valued customer,
We are excited to share a remarkable case report that highlights the potential anti-inflammatory and systemic health benefits of Bravo. This groundbreaking case report details the significant improvement in an 83-year-old patient who used our Bravo probiotic daily.
A Story of Transformation
The patient, who had established liver fibrosis, saw an incredible transformation after just six months of consistent use. His liver stiffness score, a key measure of fibrosis, dropped significantly from 7.6 kPa (moderate fibrosis) to an astonishing 3.6 kPa (absence of fibrosis).
This suggests the Bravo may have helped the body reduce inflammation and repair itself.
Beyond the Liver: A Full-Body Effect
The benefits weren't limited to the liver. The patient also showed a remarkable trend toward normalization in several key blood parameters, including Mean Corpuscular Hemoglobin (MCH), Mean Cell Hemoglobin Concentration (MCHC), glycemia, serum creatine, and Blood Urea Nitrogen (BUN). Most notably, a significant decrease in his White Blood Cell (WBC) count strongly suggests a reduction in systemic inflammation throughout his body.
These findings support our hypothesis that the unique biodiversity and postbiotic richness of Bravo contribute to these powerful systemic and anti-fibrotic effects. By potentially improving gut barrier integrity, reconstituting a healthy microbiome, and reducing inflammation, Bravo can act as a complementary non-pharmacological strategy for managing a variety of health issues.
These findings are incredibly encouraging and suggest a promising new direction for managing health.
Thank you for being a part of the Bravo community.
We are committed to supporting your journey to better health.
Sincerely,
Dr. Marco Ruggiero
